Pacira BioSciences to Participate in Fireside Chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference
August 02, 2022 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the 2022 Wedbush PacGrow Healthcare...
Pacira to Report Second Quarter 2022 Financial Results on Wednesday August 3, 2022
July 27, 2022 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., July 27, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results before the open of the U.S. markets on...
Pacira BioSciences Reports Preliminary Second Quarter 2022 Revenue of $169.4 Million
July 14, 2022 07:30 ET
|
Pacira BioSciences
TAMPA, Fla., July 14, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today...
National Safety Council and Pacira BioSciences Partner to Launch an Employee-Based Program Focused on Opioid Use and Misuse
June 16, 2022 08:00 ET
|
Pacira BioSciences
TAMPA, Fla. and ITASCA, Ill., June 16, 2022 (GLOBE NEWSWIRE) -- The National Safety Council, America’s leading nonprofit safety advocate, and Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry...
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $46.0 Million for May 2022
June 14, 2022 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., June 14, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today...
Pacira BioSciences to Participate in Fireside Chat at the Jefferies Healthcare Conference
June 02, 2022 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., June 02, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the Jefferies Healthcare Conference...
Pacira BioSciences Reports Preliminary Net Product Sales for EXPAREL and iovera° of $45.8 Million for April 2022
May 12, 2022 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today...
Pacira BioSciences to Present at Two Healthcare Conferences in May
May 10, 2022 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., May 10, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the following two healthcare...
Pacira BioSciences Reports First Quarter 2022 Financial Results
May 04, 2022 08:00 ET
|
Pacira BioSciences
-- First quarter revenue of $158 million, up 33% over prior year ---- Strong topline performance delivers net income and significantly positive adjusted EBITDA ---- Conference call today at 8:30 a.m....
Pacira to Report First Quarter 2022 Financial Results on Wednesday May 4, 2022
April 27, 2022 08:00 ET
|
Pacira BioSciences
TAMPA, Fla., April 27, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its first quarter financial results before the open of the U.S. markets on...